Clean Bill Of Health For BPA In Europe As FDA Examination Continues
This article was originally published in The Tan Sheet
Executive Summary
EFSA’s conclusion differs from decisions in Canada and the U.S. decision banning use of the substance as an epoxy resin coating in infant formula packaging. But EFSA lowers its “tolerable daily intake” level for BPA from 50 micrograms to 4 micrograms per kilogram of body weight.
You may also be interested in...
Regulatory News In Brief
NAD finds Nitraflex “strength” claim weak; FDA nixes BPA coating in infant formula packaging; Herbs of Light in the dark on GMPs, claims; AHPA floats softer Prop 65 warnings; and U.K. aims to end unlicensed herbal sales.
Regulatory News In Brief
Blood Products Advisory Committee considers at-home HIV test; Protica QC personnel fail on supplement GMPs; FDA warns pregnancy test maker of GMP, labeling violations; FDA uncovers more tainted supplements sold online; NRDC request for BPA ban short on data.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”